cll2-give trial: investigating chemotherapy-free treatment of cll
Published 7 years ago • 270 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
1:36
cll2-give trial: ibrutinib, venetoclax and obinutuzumab in patients with tp53-mutated cll
-
3:44
the cll2-bag trial: discovering an effective treatment for cll
-
1:00
the future of cll treatment: chemotherapy and targeted inhibitors
-
2:51
key btk inhibitor trials for the initial treatment of cll
-
0:49
overview of the cll2-big trial of ibrutinib and obinutuzumab
-
16:28
the latest in chronic lymphocytic leukemia (cll) treatments! | the patient story
-
7:24
what are the current cll treatment options?
-
1:01:38
new treatment guidelines to chronic lymphocytic leukemia (cll): latest advances & treatments
-
0:45
key trials in cll and designing a concept for treatment
-
1:33
future advancements in the treatment of cll
-
2:55
clinical outcomes of patients with cll receiving long-term ibrutinib in the resonate-2 study
-
1:50
targeted therapy in cll in 2022 and in the future
-
1:19
cll treatment: a look into the future
-
0:53
the future of cll treatment
-
1:28
the future of cll treatment
-
0:49
venice ii trial: health-related qol in patients with cll treated with venetoclax
-
2:59
clinical trial updates and time-limited therapy in cll
-
17:52
diagnosis and initial treatment of cll
-
1:04
the future of cll therapy
-
0:57
unanswered questions in frontline cll treatment
-
1:53
clinical outcomes of btki ven treatment in cll/sll: double-exposed vs double-refractory patients
-
0:56
the current treatment landscape in cll